Sjogren's syndrome
Information
- Disease name
- Sjogren's syndrome
- Disease ID
- DOID:12894
- Description
- "An autoimmune disease that involves attack of immune cells which destroy the exocrine glands that produce tears and saliva." [url:http\://en.wikipedia.org/wiki/Sj%C3%B6gren%27s_syndrome] {comment="ls:IEDB"}
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04541589 | Active, not recruiting | Phase 2 | Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome | January 5, 2021 | July 31, 2024 |
| NCT05016297 | Active, not recruiting | Phase 2 | Efficacy and Safety of Baricitinib in Sjogren's Syndrome | July 14, 2022 | November 22, 2024 |
| NCT03711214 | Active, not recruiting | N/A | Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome | December 1, 2018 | December 31, 2024 |
| NCT00001731 | Completed | Phase 2 | Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops | November 1997 | October 2000 |
| NCT00001852 | Completed | Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome | April 9, 1999 | November 29, 2017 | |
| NCT00001953 | Completed | The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers | November 1999 | December 2001 | |
| NCT00001954 | Completed | Phase 2 | Etanercept Therapy for Sjogren's Syndrome | December 1999 | November 2003 |
| NCT00023491 | Completed | Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells | September 2001 | October 2004 | |
| NCT00025818 | Completed | Phase 3 | Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome | May 2001 | March 2003 |
| NCT00074373 | Completed | The Research Registry for Neonatal Lupus | May 27, 2010 | June 2016 | |
| NCT00101829 | Completed | Phase 1 | Anti-CD20 Antibody Therapy for Sjogren's Syndrome | April 2004 | August 2009 |
| NCT00233363 | Completed | Phase 2 | Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome | April 15, 2005 | January 27, 2006 |
| NCT06363955 | Completed | N/A | Assessing the Efficacy of a Hydrogen Peroxide Mouthwash for Oral Wound Healing, Oral Hygiene and Xerostomia Relief | April 25, 2023 | April 1, 2024 |
| NCT00363350 | Completed | Phase 1/Phase 2 | Rituximab Treatment in Sjogren's Syndrome | August 2006 | October 2008 |
| NCT00391924 | Completed | Phase 2 | Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome | May 2000 | January 2003 |
| NCT00513591 | Completed | Duke Autoimmunity in Pregnancy Registry | August 2007 | November 19, 2018 | |
| NCT06013436 | Completed | AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry Eye | June 1, 2022 | June 1, 2023 | |
| NCT00565526 | Completed | Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome | November 26, 2007 | April 10, 2014 | |
| NCT00631358 | Completed | Phase 4 | Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention | February 2008 | |
| NCT00637793 | Completed | Phase 2 | Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome | February 2008 | November 2008 |
| NCT00750828 | Completed | Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry Mouth | January 2004 | March 2008 | |
| NCT00809003 | Completed | Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease | September 2007 | December 2007 | |
| NCT05700422 | Completed | Phase 4 | Nasal Spray Study in Sjogren's Dry Eye Disease | May 1, 2023 | August 31, 2023 |
| NCT01079871 | Completed | N/A | Evaluation of FID 114657 in Sjogren's Syndrome Subjects | February 2010 | |
| NCT05689749 | Completed | Superb Microvascular Imaging Ultrasonography of Lacrimal Gland in Patients With Sjögren Syndrome | April 1, 2021 | June 1, 2023 | |
| NCT01369589 | Completed | Phase 1/Phase 2 | An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness | November 2010 | April 2011 |
| NCT01393132 | Completed | Phase 2 | Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye | March 2011 | December 2012 |
| NCT05656196 | Completed | N/A | VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's Syndrome | April 1, 2023 | December 31, 2023 |
| NCT01601028 | Completed | Phase 3 | Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome | July 2011 | August 2013 |
| NCT01716312 | Completed | Phase 1 | Omalizumab for Lupus | January 8, 2014 | August 24, 2017 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT05015114 | Completed | Prevalence and Factors of Sarcopenia and in Patients With Primary Sjogren's Syndrome | August 12, 2021 | May 5, 2022 | |
| NCT05005806 | Completed | Phase 2/Phase 3 | Fish Oil (Omega 3 ) in Sjogren's Syndrome | September 2, 2021 | February 7, 2023 |
| NCT02203188 | Completed | N/A | Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome | August 2014 | November 2014 |
| NCT04978883 | Completed | Interstitial Lung Diseases in Primary Sjogren's Syndrome | January 1, 2016 | July 31, 2018 | |
| NCT02370225 | Completed | N/A | Aerobic Exercise in Primary Sjögren's Syndrome | March 2015 | March 2016 |
| NCT04968912 | Completed | Phase 2 | A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) | September 21, 2021 | November 30, 2023 |
| NCT02631538 | Completed | Phase 2 | Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome | February 17, 2016 | June 23, 2020 |
| NCT02661243 | Completed | N/A | Implantology and Sjögren's Syndrome | May 2015 | February 2019 |
| NCT04916756 | Completed | Phase 1/Phase 2 | A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients | January 16, 2020 | March 25, 2021 |
| NCT04895878 | Completed | Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome | May 1, 2021 | September 1, 2021 | |
| NCT02701985 | Completed | Phase 2 | A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome | July 5, 2016 | July 10, 2017 |
| NCT02920346 | Completed | Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor | March 2014 | June 16, 2020 | |
| NCT03012698 | Completed | N/A | Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye | November 1, 2017 | June 17, 2019 |
| NCT04835623 | Completed | Phase 4 | CEQUA for Sjogren's Syndrome Dry Eye | June 21, 2021 | March 21, 2024 |
| NCT04802577 | Completed | Fatigue in Primary Sjögren's Syndrome | January 4, 2021 | July 30, 2021 | |
| NCT03100942 | Completed | Phase 2 | Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome | May 1, 2017 | October 2, 2019 |
| NCT03157011 | Completed | N/A | Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome | July 17, 2017 | June 28, 2018 |
| NCT03203382 | Completed | Corneal Nerve Structure in Sjogren's | September 2015 | April 2017 | |
| NCT04649177 | Completed | N/A | Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting | December 15, 2020 | March 23, 2022 |
| NCT03247686 | Completed | Phase 2 | A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome | February 1, 2017 | August 1, 2019 |
| NCT03248518 | Completed | N/A | Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases | September 5, 2017 | November 2, 2020 |
| NCT04572841 | Completed | Phase 2 | Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) | November 12, 2020 | February 9, 2024 |
| NCT03327870 | Completed | Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population | May 1, 2018 | October 16, 2018 | |
| NCT04546542 | Completed | Hydroxychloroquine Blood Levels in Primary Sjögren Syndrome Patients | October 1, 2020 | February 22, 2024 | |
| NCT03430388 | Completed | N/A | Yellow Fever Vaccine in Patients With Rheumatic Diseases | January 31, 2018 | February 24, 2019 |
| NCT04493658 | Completed | Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye | January 11, 2021 | October 3, 2022 | |
| NCT03501420 | Completed | Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP) | June 13, 2018 | October 30, 2018 | |
| NCT03540823 | Completed | Phase 4 | Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases | April 23, 2018 | August 23, 2018 |
| NCT03578900 | Completed | Phase 4 | Quality of Life and Sjögren Syndrome | January 1, 2013 | December 31, 2016 |
| NCT03611283 | Completed | N/A | Topical Management of Xerostomia With Dry Mouth Products | October 3, 2016 | November 30, 2017 |
| NCT03719885 | Completed | N/A | TrueTear in Sjogren's Disease Patients | December 1, 2018 | December 31, 2019 |
| NCT03757065 | Completed | Cell Surface Marker Expression in Autoimmune Diseases | June 12, 2019 | October 25, 2019 | |
| NCT03817424 | Completed | Phase 1 | A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis | December 13, 2018 | July 20, 2020 |
| NCT03840538 | Completed | Phase 1/Phase 2 | Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome | January 1, 2018 | January 1, 2019 |
| NCT04345159 | Completed | Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease | April 17, 2020 | November 30, 2020 | |
| NCT03926286 | Completed | Phase 1 | Fecal Microbial Transplant (FMT) for Sjogrens Syndrome | April 15, 2019 | June 1, 2020 |
| NCT04252209 | Completed | Phase 3 | the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia | March 22, 2021 | March 15, 2023 |
| NCT00001598 | Completed | Phase 2 | DHEA Treatment for Sjogren's Syndrome | May 1997 | June 2002 |
| NCT04056221 | Completed | N/A | Effects of Acupuncture on Sjögren's Syndrome | February 18, 2019 | October 10, 2022 |
| NCT04239521 | Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata | October 1, 2020 | November 28, 2022 | |
| NCT04119128 | Completed | N/A | tDCS for Fatigue in Sjogren's Syndrome | June 3, 2019 | April 1, 2020 |
| NCT00001599 | Completed | Phase 2 | Pilot Study of Thalidomide to Treat Sjogren's Syndrome | May 1997 | June 2002 |
| NCT04749875 | Not yet recruiting | Study of Leukocyte Populations in Patients With Chronic Inflammatory | March 1, 2021 | March 1, 2026 | |
| NCT03938207 | Not yet recruiting | Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank | October 1, 2022 | December 31, 2027 | |
| NCT05056012 | Not yet recruiting | Penn SICCA Follow-up Study | July 2024 | July 2026 | |
| NCT06297213 | Not yet recruiting | Phase 1 | R-2487 in Patients With Sjogren's Syndrome (SS) | June 1, 2024 | August 30, 2026 |
| NCT06313905 | Not yet recruiting | N/A | EVADRY® in the Treatment of Xerostomia in Sjögren's Syndrome | April 15, 2024 | December 31, 2025 |
| NCT06350110 | Not yet recruiting | Phase 1/Phase 2 | Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) | November 10, 2024 | December 28, 2025 |
| NCT06364657 | Not yet recruiting | Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye | July 1, 2024 | July 31, 2027 | |
| NCT06379646 | Not yet recruiting | N/A | An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease | April 22, 2024 | April 21, 2026 |
| NCT06410742 | Not yet recruiting | Evaluation of Biopsychosocial Features, Pain, Fatigue, Quality of Life, Swallowing, and Disease-Specific Symptoms in Patients With Primer Sjogren's Syndrome | May 15, 2024 | December 30, 2024 | |
| NCT06417398 | Not yet recruiting | Early Phase 1 | Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases | May 14, 2024 | May 1, 2025 |
| NCT06420154 | Not yet recruiting | Early Phase 1 | The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases | May 27, 2024 | May 27, 2027 |
| NCT03473912 | Recruiting | Meir Medical Center Rheumatologic Biobank | April 16, 2018 | November 2037 | |
| NCT05383677 | Recruiting | Phase 2 | Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome | October 1, 2022 | August 1, 2024 |
| NCT05644795 | Recruiting | N/A | Wheat-free Diet in the Treatment of Sjogren's Syndrome | January 1, 2023 | June 30, 2025 |
| NCT01425892 | Recruiting | The Pathogenesis and Natural History of Sjogren's Disease | January 18, 2012 | ||
| NCT05715463 | Recruiting | N/A | Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity | March 1, 2023 | April 1, 2027 |
| NCT05782049 | Recruiting | N/A | Ultrasound Characteristics of the Salivary Glands in Patients With Rheumatoid Arthritis | February 2, 2023 | February 2, 2026 |
| NCT05859997 | Recruiting | N/A | Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases | May 17, 2023 | July 17, 2025 |
| NCT05879419 | Recruiting | Phase 4 | Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases | May 23, 2023 | May 22, 2027 |
| NCT05904301 | Recruiting | Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases | June 21, 2023 | June 30, 2028 | |
| NCT05927688 | Recruiting | Assessment of Physician Consideration of ePRO's, From Patients With Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments | July 18, 2023 | July 2027 | |
| NCT05958446 | Recruiting | Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women | April 14, 2022 | April 14, 2026 | |
| NCT05961267 | Recruiting | Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism | July 24, 2023 | July 2024 | |
| NCT06056921 | Recruiting | Phase 1 | Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease | August 31, 2023 | August 31, 2026 |
| NCT06104124 | Recruiting | Phase 3 | A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity | October 26, 2023 | July 28, 2026 |
| NCT06406933 | Recruiting | Salivary Conductivity Screening for Primary Sjögren's Syndrome | July 1, 2023 | March 31, 2026 | |
| NCT06312020 | Recruiting | Phase 2 | A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome | May 9, 2024 | December 26, 2026 |
| NCT06428188 | Recruiting | Phase 1/Phase 2 | Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases | May 29, 2024 | December 28, 2026 |
| NCT06324968 | Recruiting | N/A | Ro60 Expression in Macrophages in Sjogren's Disease | February 9, 2024 | February 9, 2026 |
| NCT06338735 | Recruiting | N/A | Ultra-High Frequency Ultrasonography in Sjögren's Syndrome | January 11, 2016 | December 2030 |
| NCT06339957 | Recruiting | Rheumatology Diet Study | March 1, 2024 | July 1, 2024 | |
| NCT06410833 | Recruiting | Phase 4 | Belimumab After Rituximab in Resistant Primary Juvenile SS | March 9, 2024 | December 31, 2026 |
| NCT06437652 | Recruiting | An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome | October 1, 2023 | September 30, 2024 | |
| NCT06373081 | Recruiting | N/A | Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease | April 20, 2024 | April 15, 2026 |
| NCT06454370 | Recruiting | Histopathological Analysis Versus Full-field Optical Coherence Tomography of Minor Salivary Gland Biopsy in Suspect Sjogren Syndrome | June 7, 2024 | December 7, 2024 | |
| NCT03953703 | Recruiting | Phase 2 | Levocarnitine for Dry Eye in Sjogren's Syndrome | November 17, 2021 | March 1, 2025 |
| NCT03841318 | Recruiting | N/A | Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome | August 3, 2020 | August 2024 |
| NCT04402086 | Recruiting | Rheumatology Patient Registry and Biorepository | August 4, 2020 | June 1, 2030 | |
| NCT04462601 | Recruiting | Descriptive Study of Variations in Serum Translocation Markers of the Intestinal Microbiota in Patients With Gougerot-Sjögren Syndrome According to Disease Activity | November 13, 2020 | May 2027 | |
| NCT04496960 | Recruiting | Phase 1/Phase 2 | Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome | May 18, 2021 | September 22, 2025 |
| NCT03276923 | Recruiting | Maternal Autoimmune Disease Research Alliance (MADRA) Registry | January 1, 2018 | January 1, 2027 | |
| NCT04931160 | Recruiting | N/A | B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome | February 10, 2020 | February 10, 2035 |
| NCT02327884 | Recruiting | Characterization of Diseases With Salivary Gland Involvement | April 3, 2015 | April 1, 2032 | |
| NCT06401811 | Recruiting | Reliability, Validity, and Responsiveness of the Turkish Version of Eating Assessment Tool-10 for Patients With Primer Sjögren's Syndrome | June 4, 2024 | November 30, 2024 | |
| NCT05085431 | Recruiting | Early Phase 1 | A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome | November 5, 2021 | November 5, 2024 |
| NCT04843345 | Suspended | Sjogren's Lung Study | April 1, 2021 | April 1, 2030 | |
| NCT03937856 | Terminated | N/A | Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases | May 7, 2019 | April 22, 2021 |
| NCT04839315 | Terminated | Early Phase 1 | COVID-19 Vaccination in Rheumatic Disease Patients | February 15, 2021 | February 9, 2022 |
| NCT00344448 | Terminated | Phase 2 | Pilot Study of Raptiva to Treat Sjogren's Syndrome | June 2006 | January 2009 |
| NCT00001196 | Terminated | Evaluation of Salivary Gland Dysfunction | March 23, 1984 | September 29, 2015 | |
| NCT04143841 | Terminated | N/A | Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease | October 30, 2019 | January 6, 2021 |
| NCT02031172 | Terminated | Effects of Sustained Reading on the Ocular Surface | March 2014 | June 2016 | |
| NCT04909112 | Unknown status | N/A | Olfactory and Taste Disturbances in Sjogren's Syndrome | July 1, 2022 | October 1, 2022 |
| NCT04909255 | Unknown status | Phase 4 | Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder | March 23, 2021 | August 15, 2022 |
| NCT02691377 | Unknown status | Phase 2 | Acupuncture for Primary Sjögren Syndrome | March 2016 | March 2017 |
| NCT00953485 | Unknown status | Phase 1/Phase 2 | Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS) | June 2009 | December 2011 |
| NCT02370550 | Unknown status | Phase 4 | Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome | March 2015 | December 2021 |
| NCT04313725 | Unknown status | N/A | Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease | February 24, 2020 | March 31, 2022 |
| NCT03436576 | Unknown status | Phase 3 | Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye | September 12, 2018 | November 19, 2018 |
| NCT03411850 | Unknown status | Phase 2 | Sjogrens Syndrome Measured by Ultrasound | May 2016 | December 2021 |
| NCT04653935 | Unknown status | N/A | Pilot Feasibility Study of a Sjögren's Syndrome Self-management App | January 6, 2020 | July 2021 |
| NCT03064984 | Unknown status | N/A | Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy | January 30, 2017 | September 30, 2017 |
| NCT03023592 | Unknown status | Phase 1/Phase 2 | Study of Iguratimod in Sjögren's Syndrome | February 2017 | April 2018 |
| NCT02691949 | Unknown status | Phase 2 | Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome | February 2016 | April 2018 |
| NCT05312944 | Unknown status | Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome | March 2, 2021 | March 2, 2023 | |
| NCT04397237 | Unknown status | Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe | June 10, 2020 | January 2021 | |
| NCT04530461 | Unknown status | Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases | June 1, 2020 | January 31, 2021 | |
| NCT01642706 | Unknown status | Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments | July 2, 2012 | December 2020 | |
| NCT00543166 | Unknown status | Phase 4 | Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue | February 2003 | December 2009 |
| NCT05115487 | Unknown status | Evaluation of Hand Functions in Newly Diagnosed Primary Sjögren's Syndrome | October 15, 2021 | May 7, 2023 | |
| NCT02123147 | Withdrawn | Examining the Immunological Process of Autoimmune Patients | July 2014 | August 2016 | |
| NCT01357447 | Withdrawn | Phase 1 | Pulmozyme for Sjogren's Associated Cough | May 2011 | March 2012 |
| NCT03204448 | Withdrawn | Clinical Performance of BioCLIA Ro60 | May 8, 2017 | April 16, 2020 |
- Disase is a (Disease Ontology)
- DOID:417
- Cross Reference ID (Disease Ontology)
- GARD:10252
- Cross Reference ID (Disease Ontology)
- ICD10CM:M35.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:710.2
- Cross Reference ID (Disease Ontology)
- MESH:D012859
- Cross Reference ID (Disease Ontology)
- MIM:270150
- Cross Reference ID (Disease Ontology)
- NCI:C26883
- Cross Reference ID (Disease Ontology)
- NCI:C70647
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:267875002
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:83901003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0086981
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1527336
- Exact Synonym (Disease Ontology)
- Sicca syndrome
- Exact Synonym (Disease Ontology)
- Sjogren syndrome
- Exact Synonym (Disease Ontology)
- xerodermosteosis
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012859